Novel
2-phenyl-4-quinolone compounds have potent cytotoxic effects on different human
cancer cell lines. In this study, we examined anticancer activity and mechanisms of 20-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone (CHM-1) in human osterogenic
sarcoma U-2 OS cells. CHM-1-induced apoptosis was determined by flow cytometric analysis,
DAPI staining, Comet assay, and
caspase inhibitors. CHM-1-inhibited cell migration and invasion was assessed by a wound healing assay,
gelatin zymography, and a Transwell assay. The mechanisms of CHM-1 effects on apoptosis and
metastasis signaling pathways were studied using Western blotting and gene expression. CHM-1 induced G2/M arrest and apoptosis at an IC(50) (3 microM) in U-2 OS cells and
caspase-3, -8, and -9 were activated.
Caspase inhibitors increased cell viability after exposure to CHM-1. CHM-1-induced apoptosis was associated with enhanced ROS generation, DNA damage, decreased DeltaPsi(m) levels, and promotion of mitochondrial
cytochrome c release. CHM-1 stimulated
mRNA expression of
caspase-3, -8, and -9, AIF, and Endo G. In addition, CHM-1 inhibited cell
metastasis at a low concentration (<3 microM). CHM-1 inhibited the cell
metastasis through the inhibition of MMP-2, -7, and -9. CHM-1 also decreased the levels of MAPK signaling pathways before leading to the inhibition of
MMPs. In summary, CHM-1 is a potent inducer of apoptosis, which plays a role in the anticancer activity of CHM-1.